Literature DB >> 28719329

Rift Valley Fever Seroprevalence in Coastal Kenya.

Elysse N Grossi-Soyster1, Tamara Banda2, Crystal Y Teng2, Eric M Muchiri3, Peter L Mungai3, Francis M Mutuku4,3, Ginny Gildengorin2, Uriel Kitron4, Charles H King5, A Desiree Labeaud2,1.   

Abstract

Rift Valley fever virus (RVFV) causes severe disease in both animals and humans, resulting in significant economic and public health damages. The objective of this study was to measure RVFV seroprevalence in six coastal Kenyan villages between 2009 and 2011, and characterize individual-, household-, and community-level risk factors for prior RVFV exposure. Sera were tested for anti-RVFV IgG via enzyme-linked immunosorbent assay. Overall, 51 (1.8%; confidence interval [CI95] 1.3-2.3) of 2,871 samples were seropositive for RVFV. Seroprevalence differed significantly among villages, and was highest in Jego Village (18/300; 6.0%; CI95 3.6-9.3) and lowest in Magodzoni (0/248). Adults were more likely to be seropositive than children (P < 0.001). Seropositive subjects were less likely to own land or a motor vehicle (P < 0.01), suggesting exposure is associated with lower socioeconomic standing (P = 0.03). RVFV exposure appears to be low in coastal Kenya, although with some variability among villages.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28719329      PMCID: PMC5508922          DOI: 10.4269/ajtmh.17-0104

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  23 in total

1.  Epidemiologic and clinical aspects of a Rift Valley fever outbreak in humans in Tanzania, 2007.

Authors:  Mohamed Mohamed; Fausta Mosha; Janeth Mghamba; Sherif R Zaki; Wun-Ju Shieh; Janusz Paweska; Sylvia Omulo; Solomon Gikundi; Peter Mmbuji; Peter Bloland; Nordin Zeidner; Raphael Kalinga; Robert F Breiman; M Kariuki Njenga
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

2.  Rift Valley fever in Kenya: history of epizootics and identification of vulnerable districts.

Authors:  R M Murithi; P Munyua; P M Ithondeka; J M Macharia; A Hightower; E T Luman; R F Breiman; M Kariuki Njenga
Journal:  Epidemiol Infect       Date:  2010-05-18       Impact factor: 2.451

3.  Perceived risk factors and risk pathways of Rift Valley fever in cattle in Ijara district, Kenya.

Authors:  Nelson O Owange; William O Ogara; Jacqueline Kasiiti; Peter B Gathura; Sam Okuthe; Rosemary Sang; Hippolyte Affognon; Washington Onyango-Ouma; Tobias T O Landmann; Murithi Mbabu
Journal:  Onderstepoort J Vet Res       Date:  2014-11-20       Impact factor: 1.792

4.  Rift Valley fever outbreak in livestock in Kenya, 2006-2007.

Authors:  Peninah Munyua; Rees M Murithi; Sherrilyn Wainwright; Jane Githinji; Allen Hightower; David Mutonga; Joseph Macharia; Peter M Ithondeka; Joseph Musaa; Robert F Breiman; Peter Bloland; M Kariuki Njenga
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

5.  Severe Rift Valley fever may present with a characteristic clinical syndrome.

Authors:  Summerpal S Kahlon; Clarence J Peters; James Leduc; Eric M Muchiri; Samuel Muiruri; M Kariuki Njenga; Robert F Breiman; A Clinton White; Charles H King
Journal:  Am J Trop Med Hyg       Date:  2010-03       Impact factor: 2.345

6.  Spatial and temporal heterogeneity of Anopheles mosquitoes and Plasmodium falciparum transmission along the Kenyan coast.

Authors:  Charles M Mbogo; Joseph M Mwangangi; Joseph Nzovu; Weidong Gu; Guiyan Yan; James T Gunter; Chris Swalm; Joseph Keating; James L Regens; Josephat I Shililu; John I Githure; John C Beier
Journal:  Am J Trop Med Hyg       Date:  2003-06       Impact factor: 2.345

7.  Factors associated with severe human Rift Valley fever in Sangailu, Garissa County, Kenya.

Authors:  A Desirée LaBeaud; Sarah Pfeil; Samuel Muiruri; Saidi Dahir; Laura J Sutherland; Zachary Traylor; Ginny Gildengorin; Eric M Muchiri; John Morrill; C J Peters; Amy G Hise; James W Kazura; Charles H King
Journal:  PLoS Negl Trop Dis       Date:  2015-03-12

8.  Seroepidemiological Study of Interepidemic Rift Valley Fever Virus Infection Among Persons with Intense Ruminant Exposure in Madagascar and Kenya.

Authors:  Gregory C Gray; Benjamin D Anderson; A Desirée LaBeaud; Jean-Michel Heraud; Eric M Fèvre; Soa Fy Andriamandimby; Elizabeth A J Cook; Saidi Dahir; William A de Glanville; Gary L Heil; Salah U Khan; Samuel Muiruri; Marie-Marie Olive; Lian F Thomas; Hunter R Merrill; Mary L M Merrill; Juergen A Richt
Journal:  Am J Trop Med Hyg       Date:  2015-10-12       Impact factor: 2.345

9.  Cross-sectional study of the burden of vector-borne and soil-transmitted polyparasitism in rural communities of Coast Province, Kenya.

Authors:  Donal Bisanzio; Francis Mutuku; Amaya L Bustinduy; Peter L Mungai; Eric M Muchiri; Charles H King; Uriel Kitron
Journal:  PLoS Negl Trop Dis       Date:  2014-07-24

10.  Lay perceptions of risk factors for Rift Valley fever in a pastoral community in northeastern Kenya.

Authors:  Caroline M Ng'ang'a; Salome A Bukachi; Bernard K Bett
Journal:  BMC Public Health       Date:  2016-01-13       Impact factor: 3.295

View more
  6 in total

1.  Potent neutralization of Rift Valley fever virus by human monoclonal antibodies through fusion inhibition.

Authors:  Nathaniel S Chapman; Haiyan Zhao; Nurgun Kose; Jonna B Westover; Birte Kalveram; Robin Bombardi; Jessica Rodriguez; Rachel Sutton; Joseph Genualdi; A Desiree LaBeaud; Francis M Mutuku; Phillip R Pittman; Alexander N Freiberg; Brian B Gowen; Daved H Fremont; James E Crowe
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-06       Impact factor: 11.205

Review 2.  Rift Valley fever: biology and epidemiology.

Authors:  Daniel Wright; Jeroen Kortekaas; Thomas A Bowden; George M Warimwe
Journal:  J Gen Virol       Date:  2019-07-16       Impact factor: 5.141

3.  Association between Rift Valley fever virus seroprevalences in livestock and humans and their respective intra-cluster correlation coefficients, Tana River County, Kenya.

Authors:  B Bett; J Lindahl; R Sang; M Wainaina; S Kairu-Wanyoike; S Bukachi; I Njeru; J Karanja; E Ontiri; M Kariuki Njenga; D Wright; G M Warimwe; D Grace
Journal:  Epidemiol Infect       Date:  2018-12-05       Impact factor: 2.451

4.  Paving the way for human vaccination against Rift Valley fever virus: A systematic literature review of RVFV epidemiology from 1999 to 2021.

Authors:  Keli N Gerken; A Desirée LaBeaud; Henshaw Mandi; Maïna L'Azou Jackson; J Gabrielle Breugelmans; Charles H King
Journal:  PLoS Negl Trop Dis       Date:  2022-01-24

5.  Prevalence and risk factors of Rift Valley fever in humans and animals from Kabale district in Southwestern Uganda, 2016.

Authors:  Luke Nyakarahuka; Annabelle de St Maurice; Lawrence Purpura; Elizabeth Ervin; Stephen Balinandi; Alex Tumusiime; Jackson Kyondo; Sophia Mulei; Patrick Tusiime; Julius Lutwama; John D Klena; Shelley Brown; Barbara Knust; Pierre E Rollin; Stuart T Nichol; Trevor R Shoemaker
Journal:  PLoS Negl Trop Dis       Date:  2018-05-03

Review 6.  Systematic literature review of Rift Valley fever virus seroprevalence in livestock, wildlife and humans in Africa from 1968 to 2016.

Authors:  Madeleine H A Clark; George M Warimwe; Antonello Di Nardo; Nicholas A Lyons; Simon Gubbins
Journal:  PLoS Negl Trop Dis       Date:  2018-07-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.